Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 17:6:e5464.
doi: 10.7717/peerj.5464. eCollection 2018.

Osteogenesis imperfecta: potential therapeutic approaches

Affiliations

Osteogenesis imperfecta: potential therapeutic approaches

Maxime Rousseau et al. PeerJ. .

Abstract

Osteogenesis imperfecta (OI) is a genetic disorder that is usually caused by disturbed production of collagen type I. Depending on its severity in the patient, this disorder may create difficulties and challenges for the dental practitioner. The goal of this article is to provide guidelines based on scientific evidence found in the current literature for practitioners who are or will be involved in the care of these patients. A prudent approach is recommended, as individuals affected by OI present with specific dentoalveolar problems that may prove very difficult to address. Recommended treatments for damaged/decayed teeth in the primary dentition are full-coverage restorations, including stainless steel crowns or zirconia crowns. Full-coverage restorations are also recommended in the permanent dentition. Intracoronal restorations should be avoided, as they promote structural tooth loss. Simple extractions can also be performed, but not immediately before or after intravenous bisphosphonate infusions. Clear aligners are a promising option for orthodontic treatment. In severe OI types, such as III or IV, orthognathic surgery is discouraged, despite the significant skeletal dysplasia present. Given the great variations in the severity of OI and the limited quantity of information available, the best treatment option relies heavily on the practitioner's preliminary examination and judgment. A multidisciplinary team approach is encouraged and favored in more severe cases, in order to optimize diagnosis and treatment.

Keywords: Bisphosphonates; Crowns; Dentinogenesis imperfecta; Genetics; Orthodontic; Orthodontics; Osteogenesis imperfecta; Osteonecrosis of the jaw; Rare bone disease; Surgery.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1. Subject affected by OI type IV with DI.
This picture was selected from the authors’ archives.
Figure 2
Figure 2. Panoramic radiograph of a subject affected by OI type III with missing teeth and DI.
This picture was selected from the authors’ archives.
Figure 3
Figure 3. Young subject affected by OI type III with a severe class III malocclusion.
This picture was selected from the authors’ archives.
Figure 4
Figure 4. Lateral open bite on a subject affected by OI type IV treated with the Invisalign appliance.
This picture was selected from the authors’ archives.
Figure 5
Figure 5. CBCT volume rendering of subjects affected by OI to different degrees of severity.
(A–D) OI type I subject presenting with end to end anterior relation, full cusp class III malocclusion and without sever skeletal deformities. (E–H) OI type type IV subject presenting with missing teeth, class III malocclusion with negative overjet, asymmetry and slight skeletal deformities. (I–L) OI type III subject presenting with severe class III malocclusion, anterior open bite and pronounced skeletal abnormalities. This picture was selected from the authors’ archives.

References

    1. Barron MJ, McDonnell ST, MacKie I, Dixon MJ. Hereditary dentine disorders: dentinogenesis imperfecta and dentine dysplasia. Orphanet Journal of Rare Diseases. 2008;3(1):31. doi: 10.1186/1750-1172-3-31. - DOI - PMC - PubMed
    1. Chahine C, Cheung MS, Head TW, Schwartz S, Glorieux FH, Rauch F. Tooth extraction socket healing in pediatric patients treated with intravenous pamidronate. Journal of Pediatrics. 2008;153(5):719–720. doi: 10.1016/j.jpeds.2008.05.003. - DOI - PubMed
    1. Chang PC, Lin SY, Hsu KH. The craniofacial characteristics of osteogenesis imperfecta patients. European Journal of Orthodontics. 2007;29(3):232–237. doi: 10.1093/ejo/cjl035. - DOI - PubMed
    1. Cheung MS, Arponen H, Roughley P, Azouz ME, Glorieux FH, Waltimo-Siren J, Rauch F. Cranial base abnormalities in osteogenesis imperfecta: phenotypic and genotypic determinants. Journal of Bone and Mineral Research. 2011;26(2):405–413. doi: 10.1002/jbmr.220. - DOI - PubMed
    1. Cheung MS, Glorieux FH. Osteogenesis imperfecta: update on presentation and management. Reviews in Endocrine and Metabolic Disorders. 2008;9(2):153–160. doi: 10.1007/s11154-008-9074-4. - DOI - PubMed